Squarepoint’s Chinook Therapeutics KDNY Stock Holding History
Bought
Maintained
Sold
Other funds holding KDNY
BBA
Squarepoint's KDNY Position: Q4 2022 in Review
Squarepoint sold out of Chinook Therapeutics (KDNY) in Q4 2022, closing a stake of 23,670 shares — an estimated $465K sold.
Squarepoint first reported a position in KDNY in Q4 2017 and held it in 8 quarters. The position peaked at $465K in Q3 2022. 154 funds tracked by Wall St. Rank hold KDNY as of Q4 2022.
- Squarepoint reported no remaining Chinook Therapeutics position as of Q4 2022 after selling out during the quarter.
- Squarepoint sold 23,670 Chinook Therapeutics shares in Q4 2022, an estimated $465K.
- Squarepoint first reported a position in Chinook Therapeutics in Q4 2017 and held it in 8 quarters.
- Squarepoint's Chinook Therapeutics position peaked at $465K in Q3 2022.
- 154 funds tracked by Wall St. Rank held Chinook Therapeutics as of Q4 2022.
Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.